(Q37148073)

English

Rational design of therapeutics targeting the BCL-2 family: are some cancer cells primed for death but waiting for a final push?

scientific article published on January 2008

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18437895

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18437895%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

review article

1 reference

stated in

Europe PubMed Central

title

Rational design of therapeutics targeting the BCL-2 family: are some cancer cells primed for death but waiting for a final push? (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18437895

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18437895%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

author name string

Victoria Del Gaizo Moore

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18437895

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18437895%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

Anthony Letai

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18437895

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18437895%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

language of work or name

English

0 references

publication date

1 January 2008

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18437895

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18437895%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

published in

Advances in Experimental Medicine and Biology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18437895

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18437895%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

volume

615

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18437895

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18437895%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

page(s)

159-175

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18437895

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18437895%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

Identifiers

DOI

10.1007/978-1-4020-6554-5_8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18437895

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18437895%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

PubMed publication ID

18437895

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18437895

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18437895%20AND%20SRC:MED&resulttype=core&format=json

(Q37148073)

Rational design of therapeutics targeting the BCL-2 family: are some cancer cells primed for death but waiting for a final push?

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)